Louis D. Boyajy

681 total citations
8 papers, 519 citations indexed

About

Louis D. Boyajy is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Louis D. Boyajy has authored 8 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Louis D. Boyajy's work include Pituitary Gland Disorders and Treatments (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Ophthalmology and Eye Disorders (2 papers). Louis D. Boyajy is often cited by papers focused on Pituitary Gland Disorders and Treatments (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Ophthalmology and Eye Disorders (2 papers). Louis D. Boyajy collaborates with scholars based in United States and Canada. Louis D. Boyajy's co-authors include Mark E. Molitch, William F. Young, Anne Klibanski, Connie B. Newman, Peter J. Snyder, Clinton B. Nash, Richard J. Levy, Robert F. Gagel, Шломо Мелмед and Leslie R. Sheeler and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Louis D. Boyajy

8 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louis D. Boyajy United States	7	367	188	136	68	48	8	519
E. G. Lever United Kingdom	11	310 0.8×	46 0.2×	155 1.1×	86 1.3×	33 0.7×	16	508
I Nagata Japan	10	151 0.4×	92 0.5×	77 0.6×	88 1.3×	46 1.0×	19	398
Hans Ørskov Denmark	11	341 0.9×	80 0.4×	65 0.5×	94 1.4×	56 1.2×	12	423
Amita Dasmahapatra United States	11	182 0.5×	36 0.2×	76 0.6×	71 1.0×	78 1.6×	19	401
Gökhan Erdem Türkiye	12	111 0.3×	187 1.0×	204 1.5×	66 1.0×	150 3.1×	30	590
M Montini Italy	13	744 2.0×	246 1.3×	327 2.4×	48 0.7×	5 0.1×	30	821
AB Grossman United Kingdom	7	216 0.6×	214 1.1×	78 0.6×	38 0.6×	22 0.5×	10	476
Catherine Beauregard Canada	7	530 1.4×	86 0.5×	183 1.3×	53 0.8×	42 0.9×	10	563
J Lefèbvre France	11	228 0.6×	51 0.3×	289 2.1×	191 2.8×	72 1.5×	62	572
Roman Trepp Switzerland	14	285 0.8×	71 0.4×	77 0.6×	89 1.3×	36 0.8×	38	530

Countries citing papers authored by Louis D. Boyajy

Since Specialization

Citations

This map shows the geographic impact of Louis D. Boyajy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis D. Boyajy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis D. Boyajy more than expected).

Fields of papers citing papers by Louis D. Boyajy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis D. Boyajy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis D. Boyajy. The network helps show where Louis D. Boyajy may publish in the future.

Co-authorship network of co-authors of Louis D. Boyajy

This figure shows the co-authorship network connecting the top 25 collaborators of Louis D. Boyajy. A scholar is included among the top collaborators of Louis D. Boyajy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis D. Boyajy. Louis D. Boyajy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Newman, Connie B., Шломо Мелмед, Peter J. Snyder, et al.. (1995). Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.. The Journal of Clinical Endocrinology & Metabolism. 80(9). 2768–2775. 199 indexed citations

2.

Boyajy, Louis D., et al.. (1993). Effect of chronic octreotide treatment on intestinal absorption in patients with acromegaly. Digestive Diseases and Sciences. 38(2). 309–315. 18 indexed citations

3.

Ezzat, Shereen, Peter J. Snyder, William F. Young, et al.. (1992). Octreotide Treatment of Acromegaly. Annals of Internal Medicine. 117(9). 711–718. 213 indexed citations

4.

Hanson, Ronald L., et al.. (1985). Stimulation of Insulin Secretion from Isolated Rat Islets by SaRI 59–801. Diabetes. 34(6). 548–552. 7 indexed citations

5.

Brand, Leonard, et al.. (1985). A novel, orally effective hypoglycemic agent, SaRI 59–801, in laboratory animals. Drug Development Research. 6(1). 67–77. 6 indexed citations

6.

Boyajy, Louis D. & Clinton B. Nash. (1966). Alteration of ouabain toxicity by cardiac denervation. Toxicology and Applied Pharmacology. 9(2). 199–208. 29 indexed citations

7.

Boyajy, Louis D. & Clinton B. Nash. (1965). INFLUENCE OF RESERPINE ON ARRHYTHMIAS, INOTROPIC EFFECTS, AND MYOCARDIAL POTASSIUM BALANCE INDUCED BY DIGITALIS MATERIALS. Journal of Pharmacology and Experimental Therapeutics. 148(2). 193–201. 30 indexed citations

8.

Boyajy, Louis D., et al.. (1959). Comparison of Physostigmine and Amphetamine in Antagonizing the EEG Effects of GNS Depressants.. Experimental Biology and Medicine. 102(2). 479–483. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact